T1	Participants 71 139	patients having coronary stent implantation treated with prasugrel.

T2	Participants 211 296	patients with acute coronary syndromes undergoing percutaneous coronary intervention.
T3	Participants 496 558	298 consecutive patients 68 Â± 10 years old (31% >75 years old)